Target intelligence / Profile preview

Immune cell receptors and cytokine receptors

Molecular classification
Receptor, Cytokine receptor, G protein-coupled receptor, Immunoglobulin superfamily, Tumor necrosis factor receptor superfamily
01

Overview

Immune cell receptors and cytokine receptors represent a vast and diverse group of proteins essential for the regulation and execution of the immune response. These receptors, found on various leukocytes such as T cells, B cells, and macrophages, respond to external stimuli and internal signaling molecules like cytokines, chemokines, and growth factors (StatPearls, NBK545239). Cytokine receptors, a major subset, are categorized into families based on their structural motifs and signaling pathways, such as the hematopoietin receptor family and the tumor necrosis factor (TNF) receptor superfamily (UniProt, KW-0202). In many pathological states, including autoimmune diseases and cancer, these receptor-mediated pathways are often overactive or suppressed, leading to tissue damage or immune evasion (PubMed, 25403444). Consequently, they are among the most significant classes of therapeutic targets, with numerous approved biologics and small molecules designed to modulate their activity to treat inflammatory conditions and malignancies. However, therapeutic manipulation of these receptors requires careful management due to risks like cytokine release syndrome and systemic immunosuppression.

Other names
Immune receptorsCytokine receptorsLeukocyte surface antigensImmunoreceptors
02

Mechanism of action

Drugs targeting these receptors generally function by blocking ligand binding (antagonism), neutralizing the circulating ligands, or modulating downstream signaling pathways to either suppress or enhance immune activity.

03

Biological functions

Immune responseSignal transductionInflammationCell proliferationApoptosisCell-cell communication
04

Disease associations

InflammationAutoimmune diseaseCancerInfectionAllergy
05

Safety considerations

Cytokine release syndrome (CRS)Opportunistic infectionsInfusion-related reactionsImmune-related adverse events (irAEs)Injection site reactions
06

Interacting drugs

Infliximab

6 more in the full profile.

07

Biomarkers

Soluble IL-6 receptorTNF-alpha levelsPD-L1 expressionCD20 expressionC-reactive protein (CRP)

Beyond the preview

Go deeper on Immune cell receptors and cytokine receptors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune cell receptors and cytokine receptors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call